<DOC>
	<DOCNO>NCT00616447</DOCNO>
	<brief_summary>This study compare change detect standardized rating scale ( Hamilton Anxiety Rating Scale ) score active treatment group compare sham ( placebo ) group 6 week rTMS treatment . It hop 6 week rTMS treatment lead improvement core symptom patient GAD .</brief_summary>
	<brief_title>rTMS Treatment Patients With General Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>sign patient inform consent ; primary GAD diagnosis ; HARS &gt; =15 ; male/female 1865 year ; without GAD pharmacotherapy least last 2 week take GAD medication must stable least 6 week prior start study change 6 week study treatment phase . Individual group supportive psychotherapy may continue study allow start new psychotherapy 6 week study treatment phase . current serious Axis I schizophrenia , bipolar I , MDD ; primary Axis I opinion investigator ; HDRS &gt; =18 ; metallic implant cranium except mouth ; severe/unstable medical condition ; ect within last 3 month ; history epilepsy ; neurological disorder lead increase intracranial pressure ; severe cardiac disorder/intracardiac lines/pacemakers ; current suicide risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>